Measure Lung Health From Hospital to Home
Our technology provides early detection and predictions of worsening diseases for enhanced patient care.
Our flagship product, RESP™ Smart Sensor Platform, is the world’s first FDA-cleared wearable lung device and smart sensor platform for respiratory health–enabling early, remote detection of key changes in lung acoustics and ventilation patterns.
- Validated Clinical Accuracy
- Integrates seamlessly with existing EHR clinical workflows
- Real-time access to lung data via the cloud
- Cost-effective
- Small, non-invasive and wireless device
Who We Help
Hospitals + Health Systems
Skilled Nursing Facilities
Clinical Trial Partners
Physicians + Group Practices
Payers + Payviders
Real-world, Real-time Monitoring of Lung Health
Our respiratory management solution enables real-world, real-time measuring of lung health by harnessing the power of smart sensor technologies. The RESP™ Smart Sensor Platform collects and calculates the frequency of wheezing, coughing, shortness of breath, as well as respiratory dynamics like rate and excursion for a more holistic picture of each patient’s respiratory heath journey.
The RESP™ biosensor is:
- Passive and patient-friendly
- Clinically validated to acquire lung sounds
- Utilizing proprietary AI algorithms to identify coughing and other adventitious breath sounds such as wheeze, rales, and rhonchi
*Algorithms not part of FDA clearance
RESP™ Smart Sensor Platform is the leading pulmonary management solution revolutionizing lung health
It’s now possible to measure lung health anytime, anywhere
The world’s only FDA-cleared biosensor that is clinically validated to detect both coughing, wheezing, ronchi and other adventitious breathing sounds over time without requiring episodic patient intervention.
As demonstrated in 4 ATS publications, RESP can be used continuously and has a much greater sensitivity than intermittent monitoring using an electronic stethoscope. These studies have demonstrated the greater sensitivity of the Strados RESP compared to the Littman electronic stethoscope.
RESP™ offers clinicians a cost-effective, non-invasive and wireless solution that enables early, remote detection of key changes in lung acoustics and ventilation patterns of patients.
It’s a small, unobtrusive, and hands-free biosensor—that many patients forget they are even wearing. The RESP biosensor records and stores every lung sound, whether a patient is sleeping, working out or enjoying time with family.
We designed the RESP biosensor to be non-invasive and comfortable while being easy to use, as it has no wires and is hands-free. This translates into longer wear times and an astounding 99.59% patient compliance. It also means better data for your care team, your physician and a faster time to diagnosis.
Our clinically validated bioacoustic library of sounds and RESP AI engine is the world’s largest entirely hands-free, clinical-grade dataset enabling Strados Labs to be the standard-bearer of acoustic digital biomarkers for clinical research and respiratory care globally.
Current alternatives can only count coughs, while our proprietary technology acquires stethoscope-quality sounds like wheezing, cough spasms, ronchi, and other adventitious lung sound events (including chest wall movements) without requiring episodic patient intervention.
This is a reliable method to objectively detect and effectively communicate the signs and symptoms of these patients with their care teams, in real time and at low cost.
It also provides continuous recording and identification of respiratory signs and symptoms of interest–allowing a better understanding of the progression of the patient’s respiratory status without auscultation by a clinician.
Featured In
Contact us to try RESP™ today
Talk to our Research team to learn more about how we can help